Clinical Trial Update: Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial comparing labetalol and diltiazem to control emergence blood pressure during craniotomy for brain tumor surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Hypertension

Drugs mentioned

• Diltiazem (diltiazem)
• labetalol (labetalol hydrochloride)

Snippet

Sponsor: Mahidol University | Conditions: Hypertension, Craniotomy | Phase 1, Phase 2 | Status: COMPLETED